TYP 5.00% 2.1¢ tryptamine therapeutics limited

Ann: Exopharm Gains US Patent for LEAP Technology, page-20

  1. 131 Posts.
    lightbulb Created with Sketch. 19
    Can someone please explain using FACTS (and not the nonsense references to "modern medicines" trotted out in the latest announcement) why this underachiever enjoys a lift on NO NEWS?? Moreover, the reference to use in mRNA vaccines is purely gratuitous with NO FACTS to support this: if it were true then one of the now hugely successful mRNA vaccine players would have snapped up this stinker in a NY minute. What utter dross.

    Don't be fooled by a patent grant. Actually not that hard to achieve. Harder still is to PROVE that the patent can be monetised and that it stands up to patent challenge.

    ".....the long-term future for Exopharm is in developing our own modern exosome medicines,” said Dr Ian Dixon. Well, that is code for "we failed to partner so we are going it alone." Expect a big cap raise in the next 3 months.
 
watchlist Created with Sketch. Add TYP (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.